Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VER-01 vs Beriplast P as adjunctive hemostat in cardiovascular surgery
jRCT2031230363Completed
- Sponsor
- Johnson & Johnson
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of VER-01 in intraoperative bleeding (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Primary hemostasis success at 5 minutes without re-bleeding. Started Oct 2023; status: completed.
02
Drugs
VER-01
03
Conditions
intraoperative bleeding
Beyond the preview
Go deeper on jRCT2031230363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230363.